Gemini Pharmaceuticals

Gemini Pharmaceuticals is a private, family-owned contract manufacturer serving the global dietary supplement and nutraceutical markets. With over 40 years of operational history (founded in 1995), it leverages its FDA/Health Canada registered facilities and an on-site ISO 17025 accredited laboratory to provide turnkey development and manufacturing services, including capsule and tablet production. The company's strategy is built on high-quality certifications, sustainability initiatives, and strong client partnerships, aiming to be a premier CDMO by integrating pharmaceutical standards into nutritional product manufacturing.

Integrated contract manufacturing platform featuring FDA/Health Canada registered facilities, high-speed capsule/tablet production, automated packaging lines, and an on-site ISO 17025 accredited analytical laboratory for quality control.

Gemini competes in the dietary supplement CDMO market against other contract manufacturers ranging from small private firms to large multinational corporations. Its primary competitive advantages are its ISO 17025 accredited in-house lab, pharmaceutical facility registrations, and strong sustainability profile, which differentiate it as a premium, quality-focused partner in a crowded field.